Quantum dot-based immunofluorescent imaging of Ki67 and identification of prognostic value in HER2-positive (non-luminal) breast cancer
Jin-Zhong Sun,1,* Chuang Chen,1,* Guan Jiang,2 Wei-Qun Tian,3 Yan Li,4 Sheng-Rong Sun1 1Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, People's Republic of China; 2Department of Dermatology, Renmin Hospital of Wuhan University, Wuhan, Hubei, Peo...
Guardado en:
Autores principales: | Sun JZ, Chen C, Jiang G, Tian WQ, Li Y, Sun SR |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ff06d15109e54d54be2821c99b5badfc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The prognostic value of quantitative analysis of CCL5 and collagen IV in luminal B (HER2–) subtype breast cancer by quantum-dot-based molecular imaging
por: Zhu YY, et al.
Publicado: (2018) -
Quantum dot-based immunofluorescent imaging and quantitative detection of TOP2A and prognostic value in triple-negative breast cancer
por: Zheng H, et al.
Publicado: (2016) -
Protein co-expression networks identified from HOT lesions of ER+HER2–Ki-67high luminal breast carcinomas
por: Kimito Yamada, et al.
Publicado: (2021) -
Combined Use of cyclinD1 and Ki67 for Prognosis of Luminal-Like Breast Cancer Patients
por: Junmei Hao, et al.
Publicado: (2021) -
Independent Clinical Validation of the Automated Ki67 Scoring Guideline from the International Ki67 in Breast Cancer Working Group
por: Ceren Boyaci, et al.
Publicado: (2021)